An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas

Ryan D. DeHaan, Benjamin R. Kipp, Thomas Christopher Smyrk, Susan C. Abraham, Lewis Rowland Roberts, Kevin C. Halling

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The objective of this study was to assess and compare the chromosome abnormalities present in sporadic and primary sclerosing cholangitis (PSC)-associated cholangiocarcinomas (CCAs) and biliary dysplasias. Histologic sections from 22 patients with CCA (16 sporadic and 6 PSC associated), 5 of whom had associated dysplasia, and 2 PSC patients with biliary dysplasia alone were assessed for chromosomal alterations with fluorescence in situ hybridization (FISH). FISH involved the use of a multiprobe set consisting of centromere-specific probes for chromosomes 3, 7, and 17 and a locus-specific probe for 9p21. The number of signals for each of these probes was enumerated in 50 nonoverlapping interphase nuclei, and the percentage of nuclei containing 0, 1, 2, and 3 or more signals was recorded for each probe. p16 expression was assessed using immunohistochemistry. Gain of at least 1 chromosome was identified in 19 of 22 (86%) invasive tumors and in 4 of 7 (57%) biliary dysplasias. Gain of 2 or more chromosomes (polysomy) was observed in 17 of 22 (77%) invasive tumors and in 3 of 7 (43%) biliary dysplasias. Homozygous loss of 9p21 was identified in 11 of 22 (50%) invasive tumors and in 3 of 7 (43%) biliary dysplasias. The patterns of chromosomal abnormalities detected by FISH in PSC-associated and sporadic CCAs were similar. Nine of 13 (69%) invasive tumors and 2 of 5 (40%) biliary dysplasias with complete loss of p16 expression by immunohistochemistry showed allelic loss of 9p21 by FISH. Polysomy and homozygous 9p21 deletion are common in both sporadic and PSC-associated CCAs and are frequently detectable in PSC-associated biliary dysplasia.

Original languageEnglish (US)
Pages (from-to)491-499
Number of pages9
JournalHuman Pathology
Volume38
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Sclerosing Cholangitis
Cholangiocarcinoma
Fluorescence In Situ Hybridization
Chromosome Aberrations
Neoplasms
Immunohistochemistry
Chromosomes, Human, Pair 17
Chromosomes, Human, Pair 3
Chromosomes, Human, Pair 7
Centromere
Loss of Heterozygosity
Chromosomes, Human, Pair 1
Interphase
Chromosomes

Keywords

  • Bile duct
  • Biliary tract
  • Dysplasia
  • FISH
  • Primary sclerosing cholangitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas. / DeHaan, Ryan D.; Kipp, Benjamin R.; Smyrk, Thomas Christopher; Abraham, Susan C.; Roberts, Lewis Rowland; Halling, Kevin C.

In: Human Pathology, Vol. 38, No. 3, 03.2007, p. 491-499.

Research output: Contribution to journalArticle

@article{dfb488181de8491b93f700825e68fd22,
title = "An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas",
abstract = "The objective of this study was to assess and compare the chromosome abnormalities present in sporadic and primary sclerosing cholangitis (PSC)-associated cholangiocarcinomas (CCAs) and biliary dysplasias. Histologic sections from 22 patients with CCA (16 sporadic and 6 PSC associated), 5 of whom had associated dysplasia, and 2 PSC patients with biliary dysplasia alone were assessed for chromosomal alterations with fluorescence in situ hybridization (FISH). FISH involved the use of a multiprobe set consisting of centromere-specific probes for chromosomes 3, 7, and 17 and a locus-specific probe for 9p21. The number of signals for each of these probes was enumerated in 50 nonoverlapping interphase nuclei, and the percentage of nuclei containing 0, 1, 2, and 3 or more signals was recorded for each probe. p16 expression was assessed using immunohistochemistry. Gain of at least 1 chromosome was identified in 19 of 22 (86{\%}) invasive tumors and in 4 of 7 (57{\%}) biliary dysplasias. Gain of 2 or more chromosomes (polysomy) was observed in 17 of 22 (77{\%}) invasive tumors and in 3 of 7 (43{\%}) biliary dysplasias. Homozygous loss of 9p21 was identified in 11 of 22 (50{\%}) invasive tumors and in 3 of 7 (43{\%}) biliary dysplasias. The patterns of chromosomal abnormalities detected by FISH in PSC-associated and sporadic CCAs were similar. Nine of 13 (69{\%}) invasive tumors and 2 of 5 (40{\%}) biliary dysplasias with complete loss of p16 expression by immunohistochemistry showed allelic loss of 9p21 by FISH. Polysomy and homozygous 9p21 deletion are common in both sporadic and PSC-associated CCAs and are frequently detectable in PSC-associated biliary dysplasia.",
keywords = "Bile duct, Biliary tract, Dysplasia, FISH, Primary sclerosing cholangitis",
author = "DeHaan, {Ryan D.} and Kipp, {Benjamin R.} and Smyrk, {Thomas Christopher} and Abraham, {Susan C.} and Roberts, {Lewis Rowland} and Halling, {Kevin C.}",
year = "2007",
month = "3",
doi = "10.1016/j.humpath.2006.09.004",
language = "English (US)",
volume = "38",
pages = "491--499",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas

AU - DeHaan, Ryan D.

AU - Kipp, Benjamin R.

AU - Smyrk, Thomas Christopher

AU - Abraham, Susan C.

AU - Roberts, Lewis Rowland

AU - Halling, Kevin C.

PY - 2007/3

Y1 - 2007/3

N2 - The objective of this study was to assess and compare the chromosome abnormalities present in sporadic and primary sclerosing cholangitis (PSC)-associated cholangiocarcinomas (CCAs) and biliary dysplasias. Histologic sections from 22 patients with CCA (16 sporadic and 6 PSC associated), 5 of whom had associated dysplasia, and 2 PSC patients with biliary dysplasia alone were assessed for chromosomal alterations with fluorescence in situ hybridization (FISH). FISH involved the use of a multiprobe set consisting of centromere-specific probes for chromosomes 3, 7, and 17 and a locus-specific probe for 9p21. The number of signals for each of these probes was enumerated in 50 nonoverlapping interphase nuclei, and the percentage of nuclei containing 0, 1, 2, and 3 or more signals was recorded for each probe. p16 expression was assessed using immunohistochemistry. Gain of at least 1 chromosome was identified in 19 of 22 (86%) invasive tumors and in 4 of 7 (57%) biliary dysplasias. Gain of 2 or more chromosomes (polysomy) was observed in 17 of 22 (77%) invasive tumors and in 3 of 7 (43%) biliary dysplasias. Homozygous loss of 9p21 was identified in 11 of 22 (50%) invasive tumors and in 3 of 7 (43%) biliary dysplasias. The patterns of chromosomal abnormalities detected by FISH in PSC-associated and sporadic CCAs were similar. Nine of 13 (69%) invasive tumors and 2 of 5 (40%) biliary dysplasias with complete loss of p16 expression by immunohistochemistry showed allelic loss of 9p21 by FISH. Polysomy and homozygous 9p21 deletion are common in both sporadic and PSC-associated CCAs and are frequently detectable in PSC-associated biliary dysplasia.

AB - The objective of this study was to assess and compare the chromosome abnormalities present in sporadic and primary sclerosing cholangitis (PSC)-associated cholangiocarcinomas (CCAs) and biliary dysplasias. Histologic sections from 22 patients with CCA (16 sporadic and 6 PSC associated), 5 of whom had associated dysplasia, and 2 PSC patients with biliary dysplasia alone were assessed for chromosomal alterations with fluorescence in situ hybridization (FISH). FISH involved the use of a multiprobe set consisting of centromere-specific probes for chromosomes 3, 7, and 17 and a locus-specific probe for 9p21. The number of signals for each of these probes was enumerated in 50 nonoverlapping interphase nuclei, and the percentage of nuclei containing 0, 1, 2, and 3 or more signals was recorded for each probe. p16 expression was assessed using immunohistochemistry. Gain of at least 1 chromosome was identified in 19 of 22 (86%) invasive tumors and in 4 of 7 (57%) biliary dysplasias. Gain of 2 or more chromosomes (polysomy) was observed in 17 of 22 (77%) invasive tumors and in 3 of 7 (43%) biliary dysplasias. Homozygous loss of 9p21 was identified in 11 of 22 (50%) invasive tumors and in 3 of 7 (43%) biliary dysplasias. The patterns of chromosomal abnormalities detected by FISH in PSC-associated and sporadic CCAs were similar. Nine of 13 (69%) invasive tumors and 2 of 5 (40%) biliary dysplasias with complete loss of p16 expression by immunohistochemistry showed allelic loss of 9p21 by FISH. Polysomy and homozygous 9p21 deletion are common in both sporadic and PSC-associated CCAs and are frequently detectable in PSC-associated biliary dysplasia.

KW - Bile duct

KW - Biliary tract

KW - Dysplasia

KW - FISH

KW - Primary sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=33846889537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846889537&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2006.09.004

DO - 10.1016/j.humpath.2006.09.004

M3 - Article

VL - 38

SP - 491

EP - 499

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 3

ER -